Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Human EGF Recombinant Protein

Catalog No. PIRP10927
Change view
Click to view available options
Quantity:
1000 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIRP10927 1000 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIRP10927 Supplier Invitrogen™ Supplier No. RP10927
Only null left
Add to Cart
Add to Cart

Recombinant Protein

This is a recombinant protein suitable for use as a control in ELISA and Western blot applications. Lyophilized product is stable at room temperature for 3 weeks. Store lyophilized product desiccated at -20°C. Upon reconstitution, store at 4°C for 2-7 days or aliquot and store at -20°C. For long-term storage add either HSA or BSAQ to 0.1%. Avoid repeated freeze-thaw cycles. Reconstitute using distilled water to a concentration not less than 100 μg/mL.

EGF (Epidermal growth factor) exerts its actions by binding to the EGF Receptor, a 170 kDa protein kinase. Activation of EGFR initiates diverse cellular pathways in response to toxic environmental stimuli, or to EGF binding to the receptor, the EGFR forms homo- or heterodimers with other family members. Each dimeric receptor complex initiates a distinct signaling pathway by recruiting different Src homology 2 (SH2) containing effector proteins. EGF is far and wide expressed in kidney, cerebrum, prostrate and salivary glands. EGF acts as a potent mitogenic factor and the phosphorylated receptor recruits adapter proteins like GRB2 that activates complex downstream signaling cascades. EGF activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STAT modules. Research studies suggest the protein may also play important role in activating the NF-kappa-B signaling cascade. Defects in the EGGF gene are the cause of hypomagnesemia type 4 and dysregulation has been associated with the growth and progression of certain cancers.
TRUSTED_SUSTAINABILITY

Specifications

Accession Number P01133
Concentration 0.1 mg/mL
For Use With (Application) Control
Formulation protein with no preservative
Gene ID (Entrez) 1950
Molecular Weight (g/mol) 6.2 kDa
Name Human EGF
Quantity 1000 μg
Source E. coli
Immunogen N/A
Regulatory Status RUO
Gene Alias AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone
Common Name EGF
Gene Symbol EGF
Biological Activity 1 x 10^7 Units/mg compared to reference standards
Conjugate Unconjugated
Species E. coli
Recombinant Recombinant
Sequence Human EGF recombinant protein contains 53 amino acids
Content And Storage -20°C
Expression System E. coli
Form Lyophilized
Protein Subtype Recombinant
Show More Show Less
WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.